Turn FDA cybersecurity pressure into your brand trust story backed by Siemens & Black Duck.
X-DLM™ helps medical device companies reduce cyber risk, earn the trust of enterprise buyers, auditors, and investors, and turn cybersecurity into accelerated growth.
Medical device cybersecurity is no longer a back-office AppSec issue. It is now a clearance risk, a hospital procurement screen, and a board-level revenue exposure. FDA reviewers expect SBOMs, postmarket vulnerability plans, and secure development evidence. Health systems want proof before they let a connected device reach clinical review. Investors now treat software supply chain weakness as diligence risk.
and
Why this story wins trust
MedTech buyers do not reward vague security claims. They trust governed lifecycle evidence backed by names they recognize.
Siemens Polarion ALMLifecycle evidence reviewers recognize
Siemens Polarion connects requirements, architecture decisions, code changes, tests, reviews, approvals, and release records into one governed lifecycle trail. For IEC 62304, FDA 524B, EU MDR Technical Documentation, and Design History File readiness, this is the difference between proof that exists continuously and evidence reconstructed under pressure.
Black Duck SCASBOM intelligence that survives scrutiny
Black Duck finds the components that standard scanners miss: transitive dependencies, binaries, containers, firmware, C/C++ libraries without package managers, and AI-generated open source snippets. It also surfaces vulnerability, license, component health, and malware risk so the SBOM becomes actionable product-security evidence — not a static spreadsheet for the submission folder.
X-DLM™ — The Integration LayerSiemens gives the lifecycle authority. Black Duck gives the supply chain truth. X-DLM™ makes both provable.
X-DLM™ is Electro Source's integration layer between Black Duck and Siemens Polarion. Every Black Duck vulnerability, license issue, malware signal, and component insight becomes a governed Polarion workflow with ownership, risk disposition, IEC 62304 context, and approval history. Every SBOM component links back to the release it belongs to. The evidence demanded by FDA reviewers, hospital security teams, and M&A diligence is maintained continuously — not assembled during the last sprint before submission.
What MedTech CEOs are hearing now
Cybersecurity proof now sits between your device and revenue. Reviewers, buyers, and investors are asking for evidence before they accept the story.
Of hospital procurement organizations have rejected a device on cybersecurity grounds — up from 46% in 2025. Your SBOM and vulnerability management posture is now a procurement criterion, not a documentation exercise. Source: RunSafe Medical Device Cybersecurity Index 2026.
Of hospital procurement teams will not evaluate a device without a machine-readable SBOM. SBOM absence accounts for 34% of device rejection decisions — before clinical evidence is reviewed. Black Duck generates it. X-DLM™ keeps it current.
FDA Section 524B puts connected medical-device software under a sharper evidence standard: SBOM, postmarket vulnerability management, secure development practices, and timely patch planning in the premarket package.
Days ahead of NVD that Black Duck BDSA advisories surface critical vulnerabilities on average — giving your team the response window before a disclosure event triggers an FDA postmarket notification or a hospital security alert.
Sources: RunSafe Medical Device Cybersecurity Index 2026. FDA Section 524B. Black Duck OSSRA 2026. Black Duck BDSA product documentation.
Four risks CEOs cannot delegate
This is not paperwork. It is market access, deal velocity, valuation, and trust — all exposed by the software inside the device.
FDA Delay
One missing SBOM can stall launch
FDA 524B raised the bar for connected devices: machine-readable SBOM, postmarket vulnerability management plan, secure development evidence, and patch strategy. A gap is not a formatting issue. It can become a hold, an additional information request, or a delayed clearance. Siemens Polarion and Black Duck make those artifacts part of the working lifecycle before the submission window opens.
Buyer Block
Security review happens before clinical review
Hospital security teams increasingly screen the device software story before the clinical value story gets heard. They want a current SBOM, vulnerability posture, update process, and traceability record. Black Duck produces the software supply chain evidence. Siemens Polarion shows how it is governed. X-DLM™ keeps both synchronized for the sales team.
Valuation Drag
Diligence now scans the codebase
Acquirers and investors now look for the software risks hidden inside device programs: untracked open source, license conflicts, unsupported components, binary-only dependencies, and weak postmarket records. A governed evidence chain built on Siemens Polarion and Black Duck is not just cleanup. It is diligence leverage.
AI/IP Exposure
AI code can import invisible license risk
AI-assisted development can move open source snippets into regulated software without the team recognizing the license, provenance, or vulnerability exposure. In a medical device, that can become an IP problem, a submission question, or a field-risk issue. Black Duck snippet analysis finds it before it lands in the release evidence.
Why now
The companies building this evidence chain now will be harder to displace in FDA review, hospital procurement, and M&A diligence.
IEC 62304 — Design Control
Edition 2 formally embeds cybersecurity into software lifecycle design controls. Medical device software teams scaling post-FDA approval will build either a governed, evidence-ready pipeline on Siemens Polarion and Black Duck — or an ad hoc one they will have to replace under audit pressure. The architecture you lock in now is the architecture you defend for years.
FDA 524B — After Clearance
FDA Section 524B obligations do not end at clearance. Every software update, every new component, every vulnerability disclosure must be traceable, documented, and reportable. Companies that build their SBOM and postmarket surveillance workflow on Black Duck and Polarion have a continuously maintained record. Companies that do not are building one under enforcement pressure.
Procurement — This Cycle
Health system procurement teams are evaluating cybersecurity posture in active buying cycles right now. The SBOM and vulnerability management evidence they require takes months to operationalize. The companies that bring Siemens Polarion governance and Black Duck SBOM documentation to a procurement security review are the ones that reach the clinical conversation.
Your next FDA review, hospital security review, and board meeting ask the same thing.
Can you prove the software inside your device is governed?
Book a 15-minute discovery call. We show how X-DLM™ connects Black Duck component intelligence with Siemens Polarion governance so your SBOM, vulnerability decisions, test evidence, and release approvals become one defensible cybersecurity story.
The MedTech trust equation